Cargando…

Prevalence of autism spectrum disorders in an Icelandic birth cohort

OBJECTIVES: A steady increase in the prevalence of autism spectrum disorders (ASD) has been reported in studies based on different methods, requiring adjustment for participation and missing data. Recent studies with high ASD prevalence rates rarely report on co-occurring medical conditions. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Saemundsen, Evald, Magnússon, Páll, Georgsdóttir, Ingibjörg, Egilsson, Erlendur, Rafnsson, Vilhjálmur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693420/
https://www.ncbi.nlm.nih.gov/pubmed/23788511
http://dx.doi.org/10.1136/bmjopen-2013-002748
_version_ 1782274723164454912
author Saemundsen, Evald
Magnússon, Páll
Georgsdóttir, Ingibjörg
Egilsson, Erlendur
Rafnsson, Vilhjálmur
author_facet Saemundsen, Evald
Magnússon, Páll
Georgsdóttir, Ingibjörg
Egilsson, Erlendur
Rafnsson, Vilhjálmur
author_sort Saemundsen, Evald
collection PubMed
description OBJECTIVES: A steady increase in the prevalence of autism spectrum disorders (ASD) has been reported in studies based on different methods, requiring adjustment for participation and missing data. Recent studies with high ASD prevalence rates rarely report on co-occurring medical conditions. The aim of the study was to describe the prevalence of clinically confirmed cases of ASD in Iceland and concomitant medical conditions. DESIGN: The cohort is based on a nationwide database on ASD among children born during 1994–1998. PARTICIPANTS: A total of 267 children were diagnosed with ASD, 197 boys and 70 girls. Only clinically confirmed cases were included. All received physical and neurological examination, standardised diagnostic workup for ASD, as well as cognitive testing. ASD diagnosis was established by interdisciplinary teams. Information on medical conditions and chromosomal testing was obtained by record linkage with hospital registers. SETTING: Two tertiary institutions in Iceland. The population registry recorded 22 229 children in the birth cohort. RESULTS: Prevalence of all ASD was 120.1/10 000 (95% CI 106.6 to 135.3), for boys 172.4/10 000 (95% CI 150.1 to 198.0) and for girls 64.8/10 000 (95% CI 51.3 to 81.8). Prevalence of all medical conditions was 17.2% (95% CI 13.2 to 22.2), including epilepsy of 7.1% (95% CI 4.6 to 10.8). The proportion of ASD cases with cognitive impairment (intellectual quotient <70) was 45.3%, but only 34.1% were diagnosed with intellectual disability (ID). Children diagnosed earlier or later did not differ on mean total score on a standardised interview for autism. CONCLUSIONS: The number of clinically verified cases is larger than in previous studies, yielding a prevalence of ASD on a similar level as found in recent non-clinical studies. The prevalence of co-occurring medical conditions was high, considering the low proportion of ASD cases that also had ID. Earlier detection is clearly desirable in order to provide counselling and treatment.
format Online
Article
Text
id pubmed-3693420
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36934202013-06-26 Prevalence of autism spectrum disorders in an Icelandic birth cohort Saemundsen, Evald Magnússon, Páll Georgsdóttir, Ingibjörg Egilsson, Erlendur Rafnsson, Vilhjálmur BMJ Open Epidemiology OBJECTIVES: A steady increase in the prevalence of autism spectrum disorders (ASD) has been reported in studies based on different methods, requiring adjustment for participation and missing data. Recent studies with high ASD prevalence rates rarely report on co-occurring medical conditions. The aim of the study was to describe the prevalence of clinically confirmed cases of ASD in Iceland and concomitant medical conditions. DESIGN: The cohort is based on a nationwide database on ASD among children born during 1994–1998. PARTICIPANTS: A total of 267 children were diagnosed with ASD, 197 boys and 70 girls. Only clinically confirmed cases were included. All received physical and neurological examination, standardised diagnostic workup for ASD, as well as cognitive testing. ASD diagnosis was established by interdisciplinary teams. Information on medical conditions and chromosomal testing was obtained by record linkage with hospital registers. SETTING: Two tertiary institutions in Iceland. The population registry recorded 22 229 children in the birth cohort. RESULTS: Prevalence of all ASD was 120.1/10 000 (95% CI 106.6 to 135.3), for boys 172.4/10 000 (95% CI 150.1 to 198.0) and for girls 64.8/10 000 (95% CI 51.3 to 81.8). Prevalence of all medical conditions was 17.2% (95% CI 13.2 to 22.2), including epilepsy of 7.1% (95% CI 4.6 to 10.8). The proportion of ASD cases with cognitive impairment (intellectual quotient <70) was 45.3%, but only 34.1% were diagnosed with intellectual disability (ID). Children diagnosed earlier or later did not differ on mean total score on a standardised interview for autism. CONCLUSIONS: The number of clinically verified cases is larger than in previous studies, yielding a prevalence of ASD on a similar level as found in recent non-clinical studies. The prevalence of co-occurring medical conditions was high, considering the low proportion of ASD cases that also had ID. Earlier detection is clearly desirable in order to provide counselling and treatment. BMJ Publishing Group 2013-06-20 /pmc/articles/PMC3693420/ /pubmed/23788511 http://dx.doi.org/10.1136/bmjopen-2013-002748 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
spellingShingle Epidemiology
Saemundsen, Evald
Magnússon, Páll
Georgsdóttir, Ingibjörg
Egilsson, Erlendur
Rafnsson, Vilhjálmur
Prevalence of autism spectrum disorders in an Icelandic birth cohort
title Prevalence of autism spectrum disorders in an Icelandic birth cohort
title_full Prevalence of autism spectrum disorders in an Icelandic birth cohort
title_fullStr Prevalence of autism spectrum disorders in an Icelandic birth cohort
title_full_unstemmed Prevalence of autism spectrum disorders in an Icelandic birth cohort
title_short Prevalence of autism spectrum disorders in an Icelandic birth cohort
title_sort prevalence of autism spectrum disorders in an icelandic birth cohort
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693420/
https://www.ncbi.nlm.nih.gov/pubmed/23788511
http://dx.doi.org/10.1136/bmjopen-2013-002748
work_keys_str_mv AT saemundsenevald prevalenceofautismspectrumdisordersinanicelandicbirthcohort
AT magnussonpall prevalenceofautismspectrumdisordersinanicelandicbirthcohort
AT georgsdottiringibjorg prevalenceofautismspectrumdisordersinanicelandicbirthcohort
AT egilssonerlendur prevalenceofautismspectrumdisordersinanicelandicbirthcohort
AT rafnssonvilhjalmur prevalenceofautismspectrumdisordersinanicelandicbirthcohort